New asthma drug tracked in kids: hope for better control

NCT ID NCT06427876

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 26 times

Summary

This study follows 40 children aged 6 to 14 with severe asthma that doesn't improve with standard treatments. They receive Fasenra injections to see how safe the drug is and how well it controls asthma symptoms. The goal is to manage the disease, not cure it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
RECRUITING

Aichi, Japan
Research Site
RECRUITING

Chiba, Japan
Research Site
ACTIVE_NOT_RECRUITING

Hiroshima, Japan
Research Site
RECRUITING

Hokkaido, Japan
Research Site
RECRUITING

Hyōgo, Japan
Research Site
ACTIVE_NOT_RECRUITING

Ibaraki, Japan
Research Site
RECRUITING

Mie, Japan
Research Site
RECRUITING

Okayama, Japan
Research Site
ACTIVE_NOT_RECRUITING

Osaka, Japan
Research Site
RECRUITING

Osaka, Japan
Research Site
RECRUITING

Saitama, Japan

Conditions

Explore the condition pages connected to this study.

BRONCHIAL ASTHMA